Biophytis Financials
BPTSDelisted Stock | USD 7.03 0.00 0.00% |
Biophytis |
Understanding current and past Biophytis Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Biophytis' financial statements are interrelated, with each one affecting the others. For example, an increase in Biophytis' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Biophytis' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Biophytis. Check Biophytis' Beneish M Score to see the likelihood of Biophytis' management manipulating its earnings.
Biophytis Stock Summary
Biophytis competes with NRX Pharmaceuticals, Akari Therapeutics, Armata Pharmaceuticals, Anebulo Pharmaceuticals, and Processa Pharmaceuticals. Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. The company was incorporated in 2006 and is headquartered in Paris, France. Biophytis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US09076G1040 |
Business Address | Sorbonne University, Paris, |
Sector | Biotechnology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.biophytis.com |
Phone | 33 1 44 27 23 00 |
Currency | USD - US Dollar |
Biophytis Key Financial Ratios
Return On Equity | -12.44 | |||
Return On Asset | -0.53 | |||
Target Price | 6000.0 | |||
Number Of Employees | 22 | |||
Beta | 1.05 |
Biophytis Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biophytis's current stock value. Our valuation model uses many indicators to compare Biophytis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biophytis competition to find correlations between indicators driving Biophytis's intrinsic value. More Info.Biophytis is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Biophytis by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Biophytis Market Pulse
Quote | 7.03 |
Change(%) | 0.00 |
Change | 0.00 |
Open | 7.03 |
Low | 7.03 |
High | 7.03 |
Volume | 0 |
Exchange | NASDAQ |
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Biophytis is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Biophytis has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Biophytis' financials are consistent with your investment objective using the following steps:- Review Biophytis' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Biophytis' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Biophytis' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Biophytis' stock is overvalued or undervalued.
Biophytis December 16, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Biophytis help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Biophytis. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biophytis based on widely used predictive technical indicators. In general, we focus on analyzing Biophytis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biophytis's daily price indicators and compare them against related drivers.
Information Ratio | (0.1) | |||
Maximum Drawdown | 54.12 | |||
Value At Risk | (16.20) | |||
Potential Upside | 12.41 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in Biophytis Stock
If you are still planning to invest in Biophytis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biophytis' history and understand the potential risks before investing.
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
CEOs Directory Screen CEOs from public companies around the world |